Mean weight loss induced by semaglutide and tirzepatide in obese but nondiabetic individuals
GLP-1 is a naturally occurring hormone that controls hunger, satisfaction, and blood sugar after every meal
Liver enzymes (ALT, AST) often improve in people with fatty liver disease as weight loss reduces liver fat
Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
These products specifically feed beneficial gut bacteria, potentially enhancing the effectiveness of GLP-1 medications while reducing digestive discomfort
Essentially, they slow down the gastric emptying, increasing the feeling of fullness